• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据第四版通用心肌梗死定义解读 COVID-19 相关心肌损伤亚型。

Interpretation of myocardial injury subtypes in COVID-19 disease per fourth version of Universal Definition of Myocardial Infarction.

机构信息

Department of Internal Medicine III, Cardiology, University of Heidelberg, Heidelberg, Germany.

Department Internal Medicine I, Endocrinology, University of Heidelberg, Heidelberg, Germany.

出版信息

Biomarkers. 2021 Jul;26(5):401-409. doi: 10.1080/1354750X.2021.1921031. Epub 2021 May 24.

DOI:10.1080/1354750X.2021.1921031
PMID:33998352
Abstract

BACKGROUND

Application of the 4th version of Universal Definition of Myocardial Infarction (UDMI) to characterize rates and prognostic relevance of myocardial injury in COVID-19 disease.

METHODS

This retrospective, single-centre observational study enrolled 104 patients hospitalized with SARS-CoV-2 infection. Kaplan-Meier analysis and multivariate Cox regression were used to identify influence of acute or chronic myocardial injury on a composite primary (mortality, incident acute respiratory distress syndrome, incident mechanical ventilation) and secondary endpoint (mortality, incident acute myocardial injury during hospitalization, incident venous thrombosis, pulmonary embolism or stroke).

RESULTS

A total of 27 (26.0%) patients presented with chronic myocardial injury, and 19 (18.3%) with acute myocardial injury. 42 patients(40.4%) developed an incident myocardial injury during hospitalization. The presence of acute or chronic myocardial injury on admission and incident myocardial injury during hospitalization were associated with higher rates of endpoints. Independent predictors for the primary endpoint were higher severity stages according to Siddiqi classification system and history of dyslipidaemia. Maximal hs-cTnT and D-dimer concentrations during hospitalization showed an association ( = 0.61).

CONCLUSIONS

Objective description of myocardial injury according to the 4th UDMI in the current COVID-19 pandemic is crucial in order to discriminate patients with acute myocardial infarction and acute, chronic or incident myocardial injury.

摘要

背景

应用第四版通用心肌梗死定义(UDMI)来描述 COVID-19 疾病中心肌损伤的发生率和预后相关性。

方法

这是一项回顾性、单中心观察性研究,共纳入 104 例因 SARS-CoV-2 感染住院的患者。采用 Kaplan-Meier 分析和多变量 Cox 回归分析,确定急性或慢性心肌损伤对复合主要终点(死亡率、新发急性呼吸窘迫综合征、新发机械通气)和次要终点(住院期间死亡率、新发急性心肌损伤、静脉血栓形成、肺栓塞或中风)的影响。

结果

共有 27 例(26.0%)患者存在慢性心肌损伤,19 例(18.3%)患者存在急性心肌损伤。42 例(40.4%)患者在住院期间发生新发心肌损伤。入院时存在急性或慢性心肌损伤以及住院期间新发心肌损伤与终点发生率较高有关。根据 Siddiqi 分类系统的严重程度较高和血脂异常史是主要终点的独立预测因素。住院期间 hs-cTnT 和 D-二聚体的最大浓度呈正相关( = 0.61)。

结论

在当前 COVID-19 大流行中,根据第四版 UDMI 对心肌损伤进行客观描述,对于区分急性心肌梗死、急性、慢性或新发心肌损伤患者至关重要。

相似文献

1
Interpretation of myocardial injury subtypes in COVID-19 disease per fourth version of Universal Definition of Myocardial Infarction.根据第四版通用心肌梗死定义解读 COVID-19 相关心肌损伤亚型。
Biomarkers. 2021 Jul;26(5):401-409. doi: 10.1080/1354750X.2021.1921031. Epub 2021 May 24.
2
High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19.高敏心肌肌钙蛋白 T 用于检测 COVID-19 中的心肌损伤和危险分层。
Clin Chem. 2021 Aug 5;67(8):1080-1089. doi: 10.1093/clinchem/hvab062.
3
Validation of two severity scores as predictors for outcome in Coronavirus Disease 2019 (COVID-19).验证两种严重程度评分作为 2019 年冠状病毒病(COVID-19)结局的预测指标。
PLoS One. 2021 Feb 19;16(2):e0247488. doi: 10.1371/journal.pone.0247488. eCollection 2021.
4
Impact of acute myocardial injury on prognosis in patients with COVID-19.急性心肌损伤对 COVID-19 患者预后的影响。
Eur Rev Med Pharmacol Sci. 2021 Mar;25(5):2425-2434. doi: 10.26355/eurrev_202103_25284.
5
Increased Prevalence of Myocardial Injury in Patients with SARS-CoV-2 Viremia.SARS-CoV-2 病毒血症患者心肌损伤的患病率增加。
Am J Med. 2021 Apr;134(4):542-546. doi: 10.1016/j.amjmed.2020.09.046. Epub 2020 Nov 10.
6
Clinical application of the 4th Universal Definition of Myocardial Infarction.《心肌梗死通用定义(第4版)》的临床应用
Eur Heart J. 2020 Jun 14;41(23):2209-2216. doi: 10.1093/eurheartj/ehaa035.
7
Types of myocardial injury and mid-term outcomes in patients with COVID-19.新型冠状病毒肺炎患者心肌损伤类型与中期预后。
Eur Heart J Qual Care Clin Outcomes. 2021 Sep 16;7(5):438-446. doi: 10.1093/ehjqcco/qcab053.
8
Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients.在住院的 COVID-19 患者中,心脏损伤、炎症和凝血生物标志物与结局的纵向相关性。
J Mol Cell Cardiol. 2020 Oct;147:74-87. doi: 10.1016/j.yjmcc.2020.08.008. Epub 2020 Aug 20.
9
SARS-CoV-2 Viremia is Associated With Inflammatory, But Not Cardiovascular Biomarkers, in Patients Hospitalized for COVID-19.在因新冠肺炎住院的患者中,新冠病毒血症与炎症生物标志物相关,但与心血管生物标志物无关。
J Am Heart Assoc. 2021 May 4;10(9):e019756. doi: 10.1161/JAHA.120.019756. Epub 2021 Feb 18.
10
Acute myocardial infarction in the Covid-19 era: Incidence, clinical characteristics and in-hospital outcomes-A multicenter registry.新冠疫情时代的急性心肌梗死:发生率、临床特征和住院结局——一项多中心注册研究。
PLoS One. 2021 Jun 18;16(6):e0253524. doi: 10.1371/journal.pone.0253524. eCollection 2021.

引用本文的文献

1
Use and Prognostic Implications of Cardiac Troponin in COVID-19.新型冠状病毒肺炎中心肌肌钙蛋白的应用及其预后意义。
Heart Fail Clin. 2023 Apr;19(2):163-176. doi: 10.1016/j.hfc.2022.08.005.
2
Use and Prognostic Implications of Cardiac Troponin in COVID-19.新型冠状病毒肺炎中心肌肌钙蛋白的应用及其预后意义。
Cardiol Clin. 2022 Aug;40(3):287-300. doi: 10.1016/j.ccl.2022.03.005. Epub 2022 Mar 31.
3
Cardiac Biomarkers in COVID-19: A Narrative Review.2019冠状病毒病中的心脏生物标志物:一篇叙述性综述
EJIFCC. 2021 Oct 18;32(3):337-346. eCollection 2021 Oct.